State Street Corp Applied Genetic Technologies Corp Transaction History

State Street Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.07 - $2.71 $27,611 - $69,931	-25,805 Reduced 16.89%	127,015 $136,000
Q2 2021 Aug 16, 2021	SELL	$3.62 - $5.23 $2.15 Million - $3.11 Million	-593,876 Reduced 79.53%	152,820 $598,000
Q1 2021 May 17, 2021	BUY	$3.94 - $8.19 $1.41 Million - $2.93 Million	357,566 Added 91.89%	746,696 $3.79 Million
Q4 2020 Feb 16, 2021	SELL	$3.99 - $5.7 $8,371 - $11,958	-2,098 Reduced 0.54%	389,130 $1.59 Million
Q3 2020 Nov 10, 2020	BUY	$4.38 - $6.43 $299,670 - $439,927	68,418 Added 21.19%	391,228 $1.9 Million
Q2 2020 Aug 14, 2020	BUY	$3.0 - $6.9 $968,430 - $2.23 Million	322,810 New	322,810 $1.79 Million

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.